Please provide your email address to receive an email when new articles are posted on . Weekly injectable is first new treatment for candidemia and invasive candidiasis in more than a decade. Rezzayo ...

Credit: Melinta Therapeutics. Rezzayo is supplied as a solid (cake or powder) in a single-dose vial containing 200mg of rezafungin. Rezzayo ™ (rezafungin for injection) is now available for the ...

While most people recover from fungal infections like candidiasis, it can pose a serious risk for immuno-compromised patients ...

Invasive Candida infections remain an important cause of morbidity and mortality, especially in hospitalized and immunocompromised or critically ill patients. A limited number of antifungal agents ...

Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections The Medicines and Healthcare Products Regulatory Agency (MHRA) filing ...

Please provide your email address to receive an email when new articles are posted on . Oteseconazole, an investigational oral antifungal therapy, was shown to be safe and effective in the treatment ...

Rezafungin is a next-generation, once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections, such as invasive candidiasis and candidemia The European ...

A vaccine created by University of Georgia researchers to battle multiple life-threatening fungal infections is also ...

In a recent Science Advances study, scientists have developed a novel nanozyme-probiotic combination therapy for Candida vaginitis, which shows potency in killing the causative pathogen, restoring ...

A case report of a patient with acute leukemia who developed chronic disseminated candidiasis revealed difficulties in diagnosing and treating the illness. Proper care and an accurate diagnosis were ...